• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非结核分枝杆菌肺病的遗传风险因素(系统评价)

Genetic Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease (Systematic Review).

作者信息

Sviridov P S, Litvinova M M, Karnaushkina M A, Makaryants N N, Gorbunova M V

机构信息

Laboratory Geneticist, Researcher; Research Centre for Medical Genetics, 1 Moskvorechye St., Moscow, 115522, Russia; Research Assistant; The Patrice Lumumba Peoples' Friendship University of Russia, 6 Miklukho-Maklaya St., Moscow, 117198, Russia.

MD, PhD, Associate Professor, Deputy Head of the Department for Research Work of the Department of Medical Genetics; I.M. Sechenov First Moscow State Medical University (Sechenov University), 8/2 Trubetskaya St., Moscow, 119991, Russia; Senior Researcher; The Patrice Lumumba Peoples' Friendship University of Russia, 6 Miklukho-Maklaya St., Moscow, 117198, Russia.

出版信息

Sovrem Tekhnologii Med. 2024;16(5):62-71. doi: 10.17691/stm2024.16.5.07. Epub 2024 Oct 30.

DOI:10.17691/stm2024.16.5.07
PMID:39897071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11784881/
Abstract

This paper is a systematic review of the published data describing genetic risk factors for pulmonary diseases caused by nontuberculous mycobacteria (nontuberculous mycobacterial pulmonary disease - NTM-PD). is to compile a specific list of genetic markers associated with the risk of developing NTM-PD. This literature review was prepared according to PRISMA criteria and was registered in the International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42019128569). In the process of work, a great number of articles from PubMed, Google Scholar, and ScienceDirect databases have been studied. Using careful analysis and selection procedures, a list of 14 genetic variants associated with an increased risk of developing NTM-PD was generated. genes have been found to refer to these variants as well as variants in the intergenic regions affecting expression of genes. The products of these genes take different roles in regulating the response to various pathogenic factors, and some of them are poorly understood. For a more precise and detailed explanation of the influence of these genetic variants, further studies in patient groups of different populations with the evaluation of different combinations of variants and intergenic interaction are required.

摘要

本文是一篇系统性综述,回顾了已发表的描述非结核分枝杆菌引起的肺部疾病(非结核分枝杆菌肺病 - NTM-PD)遗传风险因素的数据。目的是编制一份与NTM-PD发病风险相关的特定遗传标记列表。本综述根据PRISMA标准编制,并已在国际前瞻性系统评价注册库(PROSPERO)中注册(注册号CRD42019128569)。在工作过程中,研究了来自PubMed、谷歌学术和ScienceDirect数据库的大量文章。通过仔细的分析和筛选程序,生成了一份与NTM-PD发病风险增加相关的14个基因变异列表。已发现这些变异以及基因间区域中影响基因表达的变异所涉及的基因。这些基因的产物在调节对各种致病因素的反应中发挥不同作用,其中一些作用尚不清楚。为了更精确和详细地解释这些遗传变异的影响,需要在不同人群的患者组中进行进一步研究,评估变异的不同组合和基因间相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddd/11784881/1cf761e212a5/STM-16-5-07-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddd/11784881/c59b77949255/STM-16-5-07-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddd/11784881/1cf761e212a5/STM-16-5-07-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddd/11784881/c59b77949255/STM-16-5-07-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddd/11784881/1cf761e212a5/STM-16-5-07-f2.jpg

相似文献

1
Genetic Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease (Systematic Review).非结核分枝杆菌肺病的遗传风险因素(系统评价)
Sovrem Tekhnologii Med. 2024;16(5):62-71. doi: 10.17691/stm2024.16.5.07. Epub 2024 Oct 30.
2
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
3
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2016 Dec 19;12(12):CD010004. doi: 10.1002/14651858.CD010004.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2012 Dec 12;12:CD010004. doi: 10.1002/14651858.CD010004.pub2.
7
Simultaneous detection and differentiation of and nontuberculous mycobacteria in smear-negative sputum by a multiplex PCR assay: a clinical feasibility study.通过多重聚合酶链反应检测方法同时检测和鉴别涂片阴性痰液中的结核分枝杆菌和非结核分枝杆菌:一项临床可行性研究。
Microbiol Spectr. 2025 Jul;13(7):e0231624. doi: 10.1128/spectrum.02316-24. Epub 2025 May 30.
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Clinical presentation and treatment outcomes of extrapulmonary nontuberculous mycobacterial infections with rapid and slow growth rates in Cali, Colombia.哥伦比亚卡利市肺外非结核分枝杆菌感染的临床表现及快速和缓慢生长率的治疗结果
BMC Infect Dis. 2025 Mar 31;25(1):444. doi: 10.1186/s12879-025-10681-4.

本文引用的文献

1
Systemic assessment of solute carrier family 11-member A1 (rs17235409) gene polymorphism and Risk in Asian and caucasian population: A comprehensive updated meta-analysis.载脂蛋白 A1 (rs17235409)基因多态性与亚洲和高加索人群风险的系统性评估:一项全面的更新荟萃分析。
Int J Mycobacteriol. 2023 Oct-Dec;12(4):467-477. doi: 10.4103/ijmy.ijmy_180_23.
2
Serum iron levels in tuberculosis patients and household contacts and its association with natural resistance-associated macrophage protein 1 polymorphism and expression.肺结核患者和家庭接触者的血清铁水平及其与天然抗性相关巨噬细胞蛋白 1 多态性和表达的关系。
Clin Respir J. 2023 Sep;17(9):893-904. doi: 10.1111/crj.13677. Epub 2023 Aug 22.
3
The NLRP3 inflammasome: contributions to inflammation-related diseases.
NLRP3 炎性小体:在炎症相关疾病中的作用。
Cell Mol Biol Lett. 2023 Jun 27;28(1):51. doi: 10.1186/s11658-023-00462-9.
4
Sex-Specific Associations Between Susceptibility to Mycobacterium avium Complex Lung Disease and Programmed Cell Death 1 Gene Polymorphisms.性别特异性与对鸟分枝杆菌复合体肺病易感性和细胞程序性死亡 1 基因多态性相关。
J Infect Dis. 2023 Jun 28;228(1):18-27. doi: 10.1093/infdis/jiac396.
5
What Is Cystic Fibrosis?什么是囊性纤维化?
JAMA. 2022 Jan 11;327(2):191. doi: 10.1001/jama.2021.23280.
6
Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19.长寿巨噬细胞重编程导致 COVID-19 中 Spike 蛋白介导的炎症小体激活。
EMBO Mol Med. 2021 Aug 9;13(8):e14150. doi: 10.15252/emmm.202114150. Epub 2021 Jun 16.
7
Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.全基因组关联研究非结核分枝杆菌肺病。
Thorax. 2021 Feb;76(2):169-177. doi: 10.1136/thoraxjnl-2019-214430. Epub 2020 Oct 28.
8
Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases.非结核分枝杆菌病的流行病学、诊断与治疗。
Indian J Med Res. 2020 Sep;152(3):185-226. doi: 10.4103/ijmr.IJMR_902_20.
9
[Non - tuberculous mycobacteriosis of the lungs - diagnostic possibilities in the practice of the pulmonologist].[肺部非结核分枝杆菌病——肺科医生临床实践中的诊断可能性]
Ter Arkh. 2019 Nov 15;91(11):26-31. doi: 10.26442/00403660.2019.11.000306.
10
SLC11A1 (rs3731865) polymorphism and susceptibility to visceral leishmaniasis in HIV-coinfected patients from Northeastern Brazil.SLC11A1(rs3731865)多态性与巴西东北部 HIV 合并感染患者内脏利什曼病易感性的关系。
Parasitol Res. 2020 Feb;119(2):491-499. doi: 10.1007/s00436-019-06596-0. Epub 2020 Jan 6.